Last 12 months
Inside the activity.
0 purchase rows · 51 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 12 |
| Dec 2025 | 0 | 11 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 28, 2022 Filed Oct 31, 2022 22:46 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 574 | $108.83 | $62,465.72 |
DisclosureSEC source: 0001209191-22-054933 · doc4.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,733 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $108.55 to $109.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 23:02 UTC |
PHELAN CATHAL GDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $25.78 | $0.00 |
DisclosureSEC source: 0001209191-22-055135 · doc4.xml · derivative · entry 8 PHELAN CATHAL G · CIK 0001259761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-09-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option was approved on September 18, 2020 by the Compensation Committee of the Issuer's Board of Directors in connection with certain consulting services being provided by the Reporting Person. The Option fully vested on October 21, 2022. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 23:02 UTC |
PHELAN CATHAL GDirector
|
SaleCommon Stock | 564 | $113.36 | $63,937.13 |
DisclosureSEC source: 0001209191-22-055135 · doc4.xml · nonDerivative · entry 7 PHELAN CATHAL G · CIK 0001259761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,073 F1 · kind: The sales reported by Mr. Phelan were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F7 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $112.94 to $113.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 23:02 UTC |
PHELAN CATHAL GDirector
|
SaleCommon Stock | 700 | $112.19 | $78,532.51 |
DisclosureSEC source: 0001209191-22-055135 · doc4.xml · nonDerivative · entry 6 PHELAN CATHAL G · CIK 0001259761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,637 F1 · kind: The sales reported by Mr. Phelan were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $111.89 to $112.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 23:02 UTC |
PHELAN CATHAL GDirector
|
SaleCommon Stock | 2,836 | $111.42 | $315,973.51 |
DisclosureSEC source: 0001209191-22-055135 · doc4.xml · nonDerivative · entry 5 PHELAN CATHAL G · CIK 0001259761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,337 F1 · kind: The sales reported by Mr. Phelan were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $110.88 to $111.86, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 23:02 UTC |
PHELAN CATHAL GDirector
|
SaleCommon Stock | 4,000 | $110.35 | $441,409.60 |
DisclosureSEC source: 0001209191-22-055135 · doc4.xml · nonDerivative · entry 4 PHELAN CATHAL G · CIK 0001259761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,173 F1 · kind: The sales reported by Mr. Phelan were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $109.85 to $110.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 23:02 UTC |
PHELAN CATHAL GDirector
|
SaleCommon Stock | 700 | $109.08 | $76,359.01 |
DisclosureSEC source: 0001209191-22-055135 · doc4.xml · nonDerivative · entry 3 PHELAN CATHAL G · CIK 0001259761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,173 F1 · kind: The sales reported by Mr. Phelan were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $108.70 to $109.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 23:02 UTC |
PHELAN CATHAL GDirector
|
SaleCommon Stock | 1,200 | $108.14 | $129,768.12 |
DisclosureSEC source: 0001209191-22-055135 · doc4.xml · nonDerivative · entry 2 PHELAN CATHAL G · CIK 0001259761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,873 F1 · kind: The sales reported by Mr. Phelan were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $107.53 to $108.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 23:02 UTC |
PHELAN CATHAL GDirector
|
Exercise / conversionCommon Stock | 10,000 | $25.78 | $257,800.00 |
DisclosureSEC source: 0001209191-22-055135 · doc4.xml · nonDerivative · entry 1 PHELAN CATHAL G · CIK 0001259761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:58 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $17.75 | $0.00 |
DisclosureSEC source: 0001209191-22-055132 · doc4.xml · derivative · entry 8 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,384 Underlying: Common Stock · 9,000 shares Expires 2028-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth of the shares subject to the option vested on December 5, 2019, and 1/48th of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service to the Issuer through such date. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:58 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 1,564 | $113.28 | $177,172.27 |
DisclosureSEC source: 0001209191-22-055132 · doc4.xml · nonDerivative · entry 7 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,401 F1 · kind: The sales reported by Mr. Mecklai were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F7 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $112.75 to $113.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:58 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 3,229 | $112.01 | $361,675.12 |
DisclosureSEC source: 0001209191-22-055132 · doc4.xml · nonDerivative · entry 6 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,965 F1 · kind: The sales reported by Mr. Mecklai were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $111.50 to $112.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:58 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 6,559 | $111.02 | $728,170.34 |
DisclosureSEC source: 0001209191-22-055132 · doc4.xml · nonDerivative · entry 5 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,194 F1 · kind: The sales reported by Mr. Mecklai were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $110.50 to 111.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:58 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 5,498 | $110.18 | $605,785.58 |
DisclosureSEC source: 0001209191-22-055132 · doc4.xml · nonDerivative · entry 4 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,753 F1 · kind: The sales reported by Mr. Mecklai were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $109.47 to $110.46, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:58 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 2,250 | $108.91 | $245,038.05 |
DisclosureSEC source: 0001209191-22-055132 · doc4.xml · nonDerivative · entry 3 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,251 F1 · kind: The sales reported by Mr. Mecklai were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $108.47 to $109.37, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:58 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 1,900 | $108.04 | $205,270.68 |
DisclosureSEC source: 0001209191-22-055132 · doc4.xml · nonDerivative · entry 2 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,501 F1 · kind: The sales reported by Mr. Mecklai were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $107.42 to $108.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:58 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionCommon Stock | 9,000 | $17.75 | $159,750.00 |
DisclosureSEC source: 0001209191-22-055132 · doc4.xml · nonDerivative · entry 1 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:54 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $26.84 | $0.00 |
DisclosureSEC source: 0001209191-22-055130 · doc4.xml · derivative · entry 8 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 3,000 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth of the shares subject to the option vested on June 15, 2021, and 1/48th of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service to the Issuer through such date. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:54 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 317 | $113.36 | $35,934.74 |
DisclosureSEC source: 0001209191-22-055130 · doc4.xml · nonDerivative · entry 7 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,266 F1 · kind: The sales reported by Mr. Baker were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F7 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $112.94 to $113.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:54 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 606 | $112.14 | $67,958.54 |
DisclosureSEC source: 0001209191-22-055130 · doc4.xml · nonDerivative · entry 6 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,583 F1 · kind: The sales reported by Mr. Baker were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $111.815 to $112.46, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:54 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 1,272 | $111.19 | $141,430.88 |
DisclosureSEC source: 0001209191-22-055130 · doc4.xml · nonDerivative · entry 5 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,189 F1 · kind: The sales reported by Mr. Baker were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $110.78 to $111.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:54 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 1,728 | $110.28 | $190,569.02 |
DisclosureSEC source: 0001209191-22-055130 · doc4.xml · nonDerivative · entry 4 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,461 F1 · kind: The sales reported by Mr. Baker were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $109.755 to $110.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:54 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 402 | $109.10 | $43,859.21 |
DisclosureSEC source: 0001209191-22-055130 · doc4.xml · nonDerivative · entry 3 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,189 F1 · kind: The sales reported by Mr. Baker were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $108.70 to $109.61, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:54 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 550 | $108.12 | $59,465.40 |
DisclosureSEC source: 0001209191-22-055130 · doc4.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,591 F1 · kind: The sales reported by Mr. Baker were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $107.54 to $108.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 22:54 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionCommon Stock | 3,000 | $26.84 | $80,520.00 |
DisclosureSEC source: 0001209191-22-055130 · doc4.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2022 Filed Oct 31, 2022 22:46 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 5,000 | $108.68 | $543,423.50 |
DisclosureSEC source: 0001209191-22-054933 · doc4.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,307 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $108.09 to $109.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 13, 2022 Filed Oct 14, 2022 20:51 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 147 | $79.73 | $11,720.96 |
DisclosureSEC source: 0001209191-22-053678 · doc4.xml · nonDerivative · entry 3 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,401 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $79.62 to $80.2301, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 13, 2022 Filed Oct 14, 2022 20:51 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 280 | $79.01 | $22,121.60 |
DisclosureSEC source: 0001209191-22-053678 · doc4.xml · nonDerivative · entry 2 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,548 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $78.57 to $79.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 13, 2022 Filed Oct 14, 2022 20:46 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
SaleCommon Stock | 138 | $79.73 | $11,002.95 |
DisclosureSEC source: 0001209191-22-053673 · doc4.xml · nonDerivative · entry 3 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,859 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $79.59 to $80.2301, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 13, 2022 Filed Oct 14, 2022 20:46 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
SaleCommon Stock | 350 | $79.01 | $27,654.73 |
DisclosureSEC source: 0001209191-22-053673 · doc4.xml · nonDerivative · entry 2 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,997 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $78.57 to $79.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 13, 2022 Filed Oct 14, 2022 20:39 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 283 | $79.75 | $22,569.22 |
DisclosureSEC source: 0001209191-22-053668 · doc4.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,307 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $79.62 to $80.2301, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 13, 2022 Filed Oct 14, 2022 20:39 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 935 | $79.06 | $73,916.52 |
DisclosureSEC source: 0001209191-22-053668 · doc4.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,590 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $78.56 to $79.52, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 13, 2022 Filed Oct 14, 2022 20:35 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 96 | $79.74 | $7,655.33 |
DisclosureSEC source: 0001209191-22-053666 · doc4.xml · nonDerivative · entry 3 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,141 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $79.62 to $80.2301, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 13, 2022 Filed Oct 14, 2022 20:35 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 270 | $79.05 | $21,342.15 |
DisclosureSEC source: 0001209191-22-053666 · doc4.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,237 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $78.58 to $79.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 20:51 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,094 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053678 · doc4.xml · derivative · entry 4 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,938 Underlying: Common Stock · 1,094 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On April 12, 2021, the reporting person was granted 17,500 restricted stock units ("RSUs"), one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on October 12, 2022. F5 · derivative.expiration_date: On April 12, 2021, the reporting person was granted 17,500 restricted stock units ("RSUs"), one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on October 12, 2022. Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 20:51 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionCommon Stock | 1,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053678 · doc4.xml · nonDerivative · entry 1 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 20:46 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053673 · doc4.xml · derivative · entry 4 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On April 12, 2021, the reporting person was granted 20,000 restricted stock units ("RSUs"), one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on October 12, 2022. F5 · derivative.expiration_date: On April 12, 2021, the reporting person was granted 20,000 restricted stock units ("RSUs"), one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on October 12, 2022. Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 20:46 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053673 · doc4.xml · nonDerivative · entry 1 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 20:39 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053668 · doc4.xml · derivative · entry 5 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On April 12, 2021, the reporting person was granted 50,000 restricted stock units ("RSUs"), one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on October 12, 2022. F5 · derivative.expiration_date: On April 12, 2021, the reporting person was granted 50,000 restricted stock units ("RSUs"), one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on October 12, 2022. Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 20:39 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionCommon Stock | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053668 · doc4.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 20:35 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 938 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053666 · doc4.xml · derivative · entry 4 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On April 12, 2021, the reporting person was granted 15,000 restricted stock units ("RSUs"), one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on October 12, 2022. F5 · derivative.expiration_date: On April 12, 2021, the reporting person was granted 15,000 restricted stock units ("RSUs"), one fourth of which vested on April 12, 2022, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on October 12, 2022. Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 20:35 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionCommon Stock | 938 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053666 · doc4.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:19 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
SaleCommon Stock | 2,000 | $80.19 | $160,380.00 |
DisclosureSEC source: 0001209191-22-052738 · doc4.xml · nonDerivative · entry 1 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,097 F1 · kind: The sales reported by Mr. Dossett were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:14 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 60 | $85.24 | $5,114.40 |
DisclosureSEC source: 0001209191-22-052732 · doc4.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,400 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:14 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 1,392 | $84.75 | $117,969.22 |
DisclosureSEC source: 0001209191-22-052732 · doc4.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,460 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $84.2301 to $85.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 01, 2022 Filed Oct 3, 2022 20:44 UTC |
PHELAN CATHAL GDirector
|
GrantRestricted Stock Units · Derivative | 8,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-051867 · doc4.xml · derivative · entry 1 PHELAN CATHAL G · CIK 0001259761 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: The RSUs were approved by the Compensation Committee of the Issuer's Board of Directors in connection with certain consulting services being provided by the Reporting Person. 25% of the RSUs will vest on each of January 1, 2023, April 1, 2023, July 1, 2023 and October 1, 2023, subject in each case to the Reporting Person continuing to be a service provider on each such vesting date. F2 · derivative.expiration_date: The RSUs were approved by the Compensation Committee of the Issuer's Board of Directors in connection with certain consulting services being provided by the Reporting Person. 25% of the RSUs will vest on each of January 1, 2023, April 1, 2023, July 1, 2023 and October 1, 2023, subject in each case to the Reporting Person continuing to be a service provider on each such vesting date. Read SEC document |
| October 01, 2022 Filed Oct 5, 2022 20:14 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,906 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-052732 · doc4.xml · derivative · entry 5 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,719 Underlying: Common Stock · 3,906 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On September 5, 2019, the reporting person was granted 62,500 restricted stock units ("RSUs"), one fourth of which vested on July 1, 2020, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on October 1, 2022. F4 · derivative.expiration_date: On September 5, 2019, the reporting person was granted 62,500 restricted stock units ("RSUs"), one fourth of which vested on July 1, 2020, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on October 1, 2022. Read SEC document |
| October 01, 2022 Filed Oct 5, 2022 20:14 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionCommon Stock | 3,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-052732 · doc4.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 23:32 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 180 | $88.28 | $15,889.57 |
DisclosureSEC source: 0001209191-22-050652 · doc4.xml · nonDerivative · entry 4 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,734 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $88.17 to $88.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 23:32 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 339 | $87.80 | $29,765.12 |
DisclosureSEC source: 0001209191-22-050652 · doc4.xml · nonDerivative · entry 3 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,914 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $87.1401 to $88.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.